TY  - GEN
AU  - Chuang,Tzu-Chao
AU  - Lee,Yi-Jen
AU  - Liu,Jah-Yao
AU  - Lin,Yen-Shing
AU  - Li,Jhy-Wei
AU  - Wang,Vinchi
AU  - Law,Sai-Lung
AU  - Kao,Ming-Ching
TI  - EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs
SN  - 0006-291X
PY  - 2003///0904
KW  - Antigens, Neoplasm
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Apoptosis
KW  - Carcinoma
KW  - drug therapy
KW  - DNA Topoisomerases, Type II
KW  - DNA-Binding Proteins
KW  - Down-Regulation
KW  - Doxorubicin
KW  - Drug Delivery Systems
KW  - Drug Therapy, Combination
KW  - Epstein-Barr Virus Nuclear Antigens
KW  - genetics
KW  - Etoposide
KW  - Female
KW  - G2 Phase
KW  - Genetic Therapy
KW  - Humans
KW  - Kinetics
KW  - Mitosis
KW  - Ovarian Neoplasms
KW  - Paclitaxel
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Topoisomerase II Inhibitors
KW  - Tumor Cells, Cultured
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0006-291x(03)01235-x
ER  -